篇名 | 心肌血管重建治療的發展及現今臨床實務 |
---|---|
卷期 | 29:1 |
並列篇名 | The Development and Current Clinical Practice of Myocardial Revascularization |
作者 | 蔡劭謙 、 王志鴻 |
頁次 | 008-014 |
關鍵字 | 心肌血管重建 、 經皮冠狀動脈介入治療 、 冠狀動脈繞道手術 、 Myocardial revascularization 、 Percutaneous coronary intervention, PCI 、 Coronary artery bypass grafting, CABG 、 Scopus 、 TSCI |
出刊日期 | 201802 |
DOI | 10.6314/JIMT.201802_29(1).02 |
心肌血管重建治療目前主要是以心導管經皮冠狀動脈介入治療或者外科冠狀動脈繞道 手術來治療因冠狀動脈狹窄而造成的心肌缺氧。而冠狀動脈疾病又可分為穩定型冠狀動脈疾 病、ST 段上升急性心肌梗塞及非ST 段上升之急性冠心症。本文將介紹心肌血管重建治療的 歷史演進及在不同類型的冠狀動脈疾病,心肌血管重建治療的適應症及其益處。
Myocardial revascularization is to treat myocardial ischemia caused by coronary artery stenosis and achieved mainly by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) nowadays. The coronary artery disease can be classified into stable coronary artery disease (SCAD), ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS). This article will introduce the historic development of myocardial revascularization, the indication and benefit of myocardial revascularization for different spectrums of coronary artery diseases. (J Intern Med Taiwan 2018; 29: 8-14)